Disclosure Panels Details Page
Smoking Cessation Panel - Disclosures as of 04/20/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Douglas Arenberg MD | ACRIN PCORI |
None | None | None | 03/18/2024 |
| David Balis MD | None | None | None | None | 03/04/2024 |
| Laura Bierut MD | None | Food and Drug Administration NIH - NHGRI Research Triangle Institute |
None | Dr. Laura Bierut is listed as an inventor on a patent “Markers for Addiction” (US 20070258898), covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr. Bierut acted as a consultant for Pfizer, Inc. in 2008. | 01/22/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Paul Cinciripini PhD | Pfizer Inc. | None | None | None | 03/10/2024 |
| Susan Darlow PhD | None | None | None | None | 04/17/2024 |
| James Davis MD | I have provided time as a consultant to a company - Currax Pharmaceuticals who is developing/testing a smoking cessation medication. Total payment for my time is under $5,000. I have also provided time as a consultant to a company - Predictably Human, who is developing an FDA approved treatment fo | None | None | I have the promise of future equity in a company that currently has $0 value. They are developing what will potentially be the first FDA approved treatment for e-cigarette use. At this point the company is not public - it is not traded so my equity has $0 value. | 04/18/2024 |
| Mary Dwyer MS | None | None | None | None | 02/12/2024 |
| Donna Edmondson MSN,CRNP,AOCNP | None | None | None | None | 01/09/2024 |
| Sarah Evers-Casey MPH | None | None | None | None | 02/06/2024 |
| Josephine Feliciano MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Pfizer Inc. Regeneron Pharmactcls |
AstraZeneca Pharmaceuticals LP Bristol Myers Squibb coherus Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Regeneron Pharmactcls |
None | None | 10/13/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Brian Hitsman PhD | None | None | None | None | 04/18/2024 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 12/04/2023 |
| Karen Hudmon MS,CTTS,DrPH,BS | None | None | None | None | 04/18/2024 |
| Michael Jaklitsch MD | None | None | None | None | 03/18/2024 |
| Thomas Klingemann PharmD | None | None | None | None | 01/09/2024 |
| Pamela Ling MD,MPH | None | None | None | Tobacco Education and Research Oversight Committee, State of California | 01/26/2024 |
| Richard Matulewicz MD,MS,MSCI | None | None | None | None | 01/10/2024 |
| Danielle McCarthy PhD | None | None | None | None | 01/26/2024 |
| Beth McCullough CMSRN,RN,BS | None | None | None | None | 12/13/2023 |
| Christine McLaughlin | None | None | None | None | 03/28/2024 |
| Michael Ong PhD,MD | None | None | None | Greater Los Angeles Veteran Research and Education Foundation|State of California Tobacco Education and Research Oversight Committee|UpToDate | 03/22/2024 |
| Elyse Park PhD | None | None | None | None | 03/19/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Judith Prochaska PhD,MPH | Achieve Life Sciences Ria Health Woebot Health |
Oneleaf Plaintiff law firms in cases against tobacco companies |
None | None | 11/11/2023 |
| Argelia Sandoval MD | None | None | None | None | 11/26/2023 |
| Christine Sheffer PhD | None | None | None | None | 08/17/2023 |
| Peter Shields MD | National Cancer Institute Novartis Pharmaceuticals Corporation |
Non-pharma companies | None | None | 09/06/2023 |
| Sharon Spencer MD | None | None | None | None | 01/29/2024 |
| Jamie Studts PhD | Bristol-Myers Squibb Foundation (501Ic)3) Colorado Department of Public Health and Environment National Cancer Institute Patient-Centered Outcomes Research Institute |
Genentech, Inc. GO2 Foundation for Lung Cancer Johnson & Johnson National Lung Cancer Roundtable |
None | None | 12/17/2023 |
| Marcia Tan PhD,MPH | None | None | None | None | 02/20/2024 |
| Tawee Tanvetyanon MD,MPH | None | None | None | None | 03/18/2024 |
| Hilary Tindle MD,MPH | National Cancer Institute | None | None | None | 11/09/2023 |
| Elisa Tong MA,MD | None | None | None | None | 11/03/2023 |
| Matthew Triplette MD,MPH | American Lung Association American Thoracic Society LUNGevity foundation National Cancer Institute |
GO2 Lung Cancer Foundation Quaine McColl |
None | None | 12/07/2023 |
| James Urbanic MD | None | None | None | None | 01/21/2024 |
| Gregory Videtic MD | None | None | None | None | 04/07/2024 |
| David Warner MD | None | None | None | None | 01/26/2024 |